Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Teva Pharmaceutical Industries ADR (NY: TEVA )

18.45 +0.01 (+0.05%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Teva Pharmaceutical Industries ADR

< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
10 Health Care Stocks Showing Unusual Options Activity In Today's Session
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the market estimation of an option diverges... 
Via Benzinga
News Overload
Today US markets managed a rally despite misses in both the growth and employment data. 
Via Talk Markets
Teva Pharmaceutical Industries (TEVA) Q2 2021 Earnings Call Transcript
TEVA earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Full News Day
The US greatly increased its exports of liquified natural gas in the first half-year, to 9.6 billion cubic feet per day, a rise of 42% from a year earlier. 
Via Talk Markets
Topics Energy
Exposures Fossil Fuels
The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc... 
Via Benzinga
Exposures COVID-19
Earnings Scheduled For July 28, 2021
Companies Reporting Before The Bell • Barclays (NYSE:BCS) is likely to report quarterly earnings at $0.55 per share on revenue of $7.90 billion. • United... 
Via Benzinga
62 Biggest Movers From Yesterday
Gainers Flora Growth Corp. (NASDAQ: FLGC) surged 63.1% to close at $8.27. The Miami-based cannabis producer confirmed Tuesday it has signed a non-binding letter of intent to... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Teva Stock Falls After COVID-19 Impacts Q2 Top And Bottomline; Lowers FY21 Outlook
Teva Pharmaceutical Industries Ltd Q2 sales reached $3.9 billion, increasing 1% Y/Y or decreasing 2% in local currency terms, missing the consensus of $4.04 billion. 
Via Talk Markets
Exposures COVID-19
50 Stocks Moving In Wednesday's Mid-Day Session
Gainers Infinity Pharmaceuticals Inc. (NASDAQ: INFI) shares jumped 59.9% to $2.43. Infinity Pharmaceuticals shares tumbled over 31% on Tuesday after the company highlighted the... 
Via Benzinga
Teva Stock Falls After COVID-19 Impacts Q2 Top And Bottomline; Lowers FY21 Outlook
Teva Pharmaceutical Industries Ltd (NYSE: TEVA) Q2 sales reached $3.9 billion, increasing 1% Y/Y or decreasing 2% in local currency terms, missing the consensus of $4.... 
Via Benzinga
Exposures COVID-19
Teva Generic Medicines Saved the United States $28.8 Billion in 2020, and a Total of $43.1 Billion Across Major Markets, According to Independent Analysis
From Teva Pharmaceutical Industries Limited
Via Business Wire
Recap: Teva Pharmaceutical Q2 Earnings
Shares of Teva Pharmaceutical Indus (NYSE:TEVA) fell 2.5% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 7.27%... 
Via Benzinga
Teva Reports Second Quarter 2021 Financial Results
From Teva Pharmaceutical Industries Limited
Via Business Wire
Banned Merger
Today stock markets are in disarray after the full horror of Beijing's attack on Chinese capitalism has been understood. 
Via Talk Markets
Analyzing Teva Pharmaceutical Indus's Unusual Options Activity
On Friday, shares of Teva Pharmaceutical Indus (NYSE:TEVA) saw unusual options activity. After the option alert, the stock price moved down to $8.84. Sentiment: BEARISH Option... 
Via Benzinga
Joblessness Surprise
Despite higher production for the Emirates the price of oil rose sharply today. More output should cut prices. 
Via Talk Markets
Panic Attack
The H1 rise in US markets was based on hope for an end to lockdowns. 
Via Talk Markets
Understanding Teva Pharmaceutical Indus's Unusual Options Activity
Shares of Teva Pharmaceutical Indus (NYSE:TEVA) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved up to $8.98. Sentiment... 
Via Benzinga
Teva Announces Changes to Executive Management Team
From Teva Pharmaceutical Industries Limited
Via Business Wire
“Claw-Back” day
The rally was just as irrational as the selloff. 
Via Talk Markets
Drug Stocks McKesson, AmerisourceBergen Pop On Reports Of $26 Billion Settlement In Opioid Fight
Drug stocks popped Tuesday on reports they could pay $21 billion to settle claims they helped fuel the nation's opioid epidemic. 
Via Investor's Business Daily
Topics Lawsuit
Exposures Financial Legal
Delta Defeats Bulls
Stocks tended to crash without rhyme or reason. 
Via Talk Markets
Unusual Options Activity Insight: Teva Pharmaceutical Indus
On Monday, shares of Teva Pharmaceutical Indus (NYSE:TEVA) saw unusual options activity. After the option alert, the stock price moved down to $8.38. Sentiment: BULLISH Option... 
Via Benzinga
Weak Week
Friday tried a recovery because retail sales data for June were strong, particularly in dining out, although in the end, the weak tech side cut the optimism. 
Via Talk Markets
Stocks That Hit 52-Week Lows On Monday
Stocks That Hit 52-Week Lows On Monday Monday morning, 285 companies reached new 52-week lows. Noteworthy Points: The largest company by market cap to set a new 52-week... 
Via Benzinga
Selloff Round 3
Stocks fell across the board in foreign countries, except for Britain which was upbeat. 
Via Talk Markets
Yellow Card
The price of oil fell about 1% today. 
Via Talk Markets
Analyzing Teva Pharmaceutical Indus's Unusual Options Activity
On Monday, shares of Teva Pharmaceutical Indus (NYSE:TEVA) saw unusual options activity. After the option alert, the stock price moved up to $9.31. Sentiment: BEARISH Option... 
Via Benzinga
Recovery Friday
The big winners this week were Financials. 
Via Talk Markets
Biohaven Stock Hits Record High As Migraine Drug Trounces Quarterly Forecasts
Biohaven crushed Wall Street's expectations for second-quarter sales of migraine drug Nurtec on Tuesday, leading BHVN stock to pop. 
Via Investor's Business Daily
< Previous 1 2
...
18 19 20 21 22 23 24 25 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.